miR-132 serves as a diagnostic biomarker in gestational diabetes mellitus and its regulatory effect on trophoblast cell viability

BACKGROUND: Gestational diabetes mellitus (GDM) leads to poor pregnancy outcomes. Strategies that improve trophoblast cell function are important methods for GDM treatment. This study aimed to investigate the expression and diagnostic potential of microRNA-132 (miR-132) in GDM patients, and further...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Xuegui, Xiang, Cuiping, Zheng, Xiaoxia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6814988/
https://www.ncbi.nlm.nih.gov/pubmed/31653266
http://dx.doi.org/10.1186/s13000-019-0899-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6814988/
https://www.ncbi.nlm.nih.gov/pubmed/31653266
http://dx.doi.org/10.1186/s13000-019-0899-9

Ejemplares similares